Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Semaglutide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Semaglutide 1mg/0.74ml inj 3ml pre-filled disposable devices
0601023AWAAACAC
|
Semaglutide | Semaglutide | Endocrine System | 30,170 |
|
Semaglutide 7mg tablets
0601023AWAAAFAF
|
Semaglutide | Semaglutide | Endocrine System | 29,301 |
|
Semaglutide 14mg tablets
0601023AWAAADAD
|
Semaglutide | Semaglutide | Endocrine System | 23,255 |
|
Semaglutide 3mg tablets
0601023AWAAAEAE
|
Semaglutide | Semaglutide | Endocrine System | 15,613 |
|
Semaglutide 0.5mg/0.37ml inj 1.5ml pf dispos dev
0601023AWAAABAB
|
Semaglutide | Semaglutide | Endocrine System | 12,416 |
|
Semaglutide 0.25mg/0.19ml inj 1.5ml pf dispos dev
0601023AWAAAAAA
|
Semaglutide | Semaglutide | Endocrine System | 6,108 |
|
Semaglutide 1mg/0.75ml inj 3ml pre-filled disposable devices
0601023AWAAAIAI
|
Semaglutide | Semaglutide | Endocrine System | 704 |
|
Semaglutide 1.7mg/0.75ml inj 3ml pf dispos dev
0601023AWAAAHAH
|
Semaglutide | Semaglutide | Endocrine System | 355 |
|
Semaglutide 0.25mg/0.37ml inj 1.5ml pf dispos dev
0601023AWAAAGAG
|
Semaglutide | Semaglutide | Endocrine System | 307 |
|
Semaglutide 2.4mg/0.75ml inj 3ml pf dispos dev
0601023AWAAAJAJ
|
Semaglutide | Semaglutide | Endocrine System | 251 |
|
Semaglutide 1.5mg tablets
0601023AWAAAKAK
|
Semaglutide | Semaglutide | Endocrine System | No data available |
|
Semaglutide 4mg tablets
0601023AWAAALAL
|
Semaglutide | Semaglutide | Endocrine System | No data available |
|
Semaglutide 9mg tablets
0601023AWAAAMAM
|
Semaglutide | Semaglutide | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.